By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Relmada Therapeutics 



  New York    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS








Company News
Relmada Therapeutics Appoints Christopher W. James As Senior Director Of Clinical Development 9/18/2014 9:00:07 AM
Relmada Therapeutics Enters Into Agreement With Memorial Sloan-Kettering Cancer Center To Better Clarify Unique Mechanism Of Action For LevoCap ER 9/16/2014 8:58:29 AM
Relmada Therapeutics Announces The Filing Of Clinical Trial Application In Canada For d-methadone 9/10/2014 7:49:10 AM
Relmada Therapeutics Provides Its First Corporate Update As A Public Company 9/9/2014 8:56:07 AM
Relmada Therapeutics To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2014 9/4/2014 2:14:50 PM
Relmada Therapeutics Completes Name Change And Announces New Ticker 8/6/2014 9:03:55 AM
Camp Nine Inc. Announces Corporate Name Change To Relmada Therapeutics 7/9/2014 9:30:01 AM
Relmada Therapeutics Files Shares Registration Statement 7/1/2014 10:04:30 AM
Relmada Therapeutics To Present At The 2014 Biotechnology Industry Organization (BIO) International Convention 6/19/2014 7:38:35 AM
Relmada Therapeutics Successfully Completes Offerings Totaling $28 Million In Connection With Going Public Transaction 6/16/2014 6:40:18 AM
12
//-->